{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:21:33Z","timestamp":1790263293403,"version":"4.1.0"},"reference-count":73,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T00:00:00Z","timestamp":1600387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2020.571553","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T11:28:10Z","timestamp":1600428490000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Small Non-coding RNAs: Do They Encode Answers for Controlling SARS-CoV-2 in the Future?"],"prefix":"10.3389","volume":"11","author":[{"given":"Pallabi","family":"Bhattacharyya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhas C.","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"865.e12","DOI":"10.1016\/j.cell.2020.04.020","article-title":"Development of CRISPR as an antiviral strategy to combat SARS-CoV-2 and influenza.","volume":"181","author":"Abbott","year":"2020","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41591-020-0820-9","article-title":"The proximal origin of SARS-CoV-2.","volume":"26","author":"Andersen","year":"2020","journal-title":"Nat. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.4155\/fmc.14.116","article-title":"miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents.","volume":"6","author":"Baumann","year":"2014","journal-title":"Fut. Med. Chem."},{"key":"B4","doi-asserted-by":"publisher","first-page":"5282","DOI":"10.1073\/pnas.0810909106","article-title":"Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals.","volume":"106","author":"Bazzoni","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B5","first-page":"114","article-title":"How close are miRNAs from clinical practice? A perspective on the diagnostic and therapeutic market.","volume":"30","author":"Bonneau","year":"2019","journal-title":"Electr. J. Int. Fed. Clin. Chem. Lab. Med."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.00824","article-title":"Viruses and miRNAs: more friends than foes.","volume":"8","author":"Bruscella","year":"2017","journal-title":"Front. Microbiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"7838","DOI":"10.18632\/oncotarget.3046","article-title":"Gold nano-particles (AuNPs) carrying anti-EBV-miR-BART7-3p inhibit growth of EBV-positive nasopharyngeal carcinoma.","volume":"6","author":"Cai","year":"2015","journal-title":"Oncotarget"},{"key":"B8","year":"2020","journal-title":"Coronavirus."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2020.04.002","article-title":"Genomics functional analysis and drug screening of SARS-CoV-2.","author":"Chen","year":"2020","journal-title":"Genes Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/cr.2016.21","article-title":"An Ebola virus-encoded microRNA-like fragment serves as a biomarker for early diagnosis of Ebola virus disease.","volume":"26","author":"Chen","year":"2016","journal-title":"Cell Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev-virology-031413-085439","article-title":"Balance and stealth: the role of noncoding RNAs in the regulation of virus gene expression.","volume":"1","author":"Cox","year":"2014","journal-title":"Ann. Rev. Virol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"9029","DOI":"10.1128\/JVI.01331-15","article-title":"The nucleocapsid protein of coronaviruses acts as a viral suppressor of RNA silencing in mammalian cells.","volume":"89","author":"Cui","year":"2015","journal-title":"J. Virol."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.9369","article-title":"Computational analysis of microRNA- mediated interactions in SARS-CoV-2 infection.","volume":"8","author":"Demirci","year":"2020","journal-title":"PeerJ"},{"key":"B14","doi-asserted-by":"publisher","first-page":"270","DOI":"10.4161\/rna.8.2.15013","article-title":"Coronaviruses.","volume":"8","author":"Denison","year":"2011","journal-title":"RNA Biol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3851\/IMP2064","article-title":"The promise, pitfalls and progress of RNA-interference-based antiviral therapy for respiratory viruses.","volume":"17","author":"DeVincenzo","year":"2012","journal-title":"Anti. Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1166\/jbn.2014.1929","article-title":"RNA interference-based therapeutics: molecular platforms for infectious diseases.","volume":"10","author":"Dyawanapelly","year":"2014","journal-title":"J. Biomed. Nanotechnol."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/srep03883","article-title":"Systemic delivery of miR-126 by miRNA-loaded bubble liposomes for the treatment of hindlimb ischemia.","volume":"4","author":"Endo-Takahashi","year":"2015","journal-title":"Sci. Rep."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0197246","article-title":"Host-directed combinatorial RNAi improves inhibition of diverse strains of influenza A virus in human respiratory epithelial cells.","volume":"13","author":"Estrin","year":"2018","journal-title":"PLoS One"},{"key":"B19","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nrg2290","article-title":"Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?","volume":"9","author":"Filipowicz","year":"2008","journal-title":"Nat. Rev. Genet."},{"key":"B20","doi-asserted-by":"publisher","first-page":"826.e11","DOI":"10.1016\/j.molcel.2019.09.013","article-title":"Programmable inhibition and detection of RNA viruses using Cas13.","volume":"76","author":"Freije","year":"2019","journal-title":"Mol. Cell"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1186\/s41544-019-0024-y","article-title":"Recent progress in microRNA-based delivery systems for the treatment of human disease.","volume":"1","author":"Fu","year":"2019","journal-title":"ExRNA"},{"key":"B22","doi-asserted-by":"publisher","first-page":"509","DOI":"10.14336\/ad.2020.0428","article-title":"COVID-19 virulence in aged patients might be impacted by the host cellular MicroRNAs abundance \/ profile.","volume":"11","author":"Fulzele","year":"2020","journal-title":"Aging Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.00478","article-title":"The potential for microRNA therapeutics and clinical research.","volume":"10","author":"Hanna","year":"2019","journal-title":"Front. Genet."},{"key":"B25","doi-asserted-by":"publisher","first-page":"4626","DOI":"10.1093\/nar\/gks026","article-title":"Biogenesis of mammalian microRNAs by a non-canonical processing pathway.","volume":"40","author":"Havens","year":"2012","journal-title":"Nucl. Acids Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/v12060614","article-title":"The prediction of miRNAs in SARS-CoV-2 genomes?: host responses and virus pathogenicity-related KEGG pathways significant for comorbidities.","volume":"12","author":"Identify","year":"2020","journal-title":"Viruses"},{"key":"B28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.17582\/journal.bjv\/2015\/2.3.28.31","article-title":"Harnessing the power of miRNAs in influenza A virus research.","volume":"2","author":"Izzard","year":"2015","journal-title":"Br. J. Virol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"4963","DOI":"10.2147\/IJN.S138400","article-title":"Gold nanoparticle-based miR155 antagonist macrophage delivery restores the cardiac function in ovariectomized diabetic mouse model.","volume":"12","author":"Jia","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1126\/science.1113329","article-title":"Molecular biology: modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA.","volume":"309","author":"Jopling","year":"2005","journal-title":"Science"},{"key":"B31","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1002\/jgm.929","article-title":"RNA interference for antiviral therapy.","volume":"8","author":"Ketzinel-Gilad","year":"2006","journal-title":"J. Gene Med."},{"key":"B32","first-page":"12","article-title":"RNA-cleaving properties of human apurinic\/apyrimidinic endonuclease 1 (APE1).","volume":"1","author":"Kim","year":"2010","journal-title":"Int. J. Biochem. Mol. Biol."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003018","article-title":"Virus-encoded microRNAs: an overview and a look to the future.","volume":"8","author":"Kincaid","year":"2012","journal-title":"PLoS Pathog."},{"key":"B34","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1128\/jvi.02678-13","article-title":"Human coronavirus OC43 nucleocapsid protein binds MicroRNA 9 and potentiates NF- B activation.","volume":"88","author":"Lai","year":"2014","journal-title":"J. Virol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/sj.gt.3302645","article-title":"Antiviral RNAi therapy: emerging approaches for hitting a moving target.","volume":"13","author":"Leonard","year":"2006","journal-title":"Gene Ther."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41544-018-0004-7","article-title":"microRNAs in viral acute respiratory infections: immune regulation, biomarkers, therapy, and vaccines.","volume":"1","author":"Leon-Icaza","year":"2019","journal-title":"ExRNA"},{"key":"B37","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jconrel.2015.04.001","article-title":"Generation of a safe and effective live viral vaccine by virus self-attenuation using species-specific artificial microRNA.","volume":"207","author":"Li","year":"2015","journal-title":"J. Control. Release"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007837","article-title":"MicroRNome analysis unravels the molecular basis of SARS infection in bronchoalveolar stem cells.","volume":"4","author":"Mallick","year":"2009","journal-title":"PLoS One"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.01800","article-title":"Geographic and genomic distribution of SARS-CoV-2 mutations.","volume":"11","author":"Mercatelli","year":"2020","journal-title":"Front. Microbiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.1073\/pnas.0508200103","article-title":"Discovery of an RNA virus 3\u2032?5\u2032 exoribonuclease that is critically involved in coronavirus RNA synthesis.","volume":"103","author":"Minskaia","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.03079","article-title":"The Interplay Between Viral-Derived miRNAs and Host Immunity During Infection.","volume":"10","author":"Mishra","year":"2020","journal-title":"Front. Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1038\/nm.2791","article-title":"Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2.","volume":"18","author":"Miyazaki","year":"2012","journal-title":"Nat. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.chom.2017.01.015","article-title":"SARS-CoV-encoded small RNAs contribute to infection-associated lung pathology.","volume":"21","author":"Morales","year":"2017","journal-title":"Cell Host Microbe"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/718743","article-title":"Inhibition of hepatitis B virus replication by helper dependent adenoviral vectors expressing artificial anti-HBV Pri-miRs from a liver-specific promoter.","volume":"2014","author":"Mowa","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"B45","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.actbio.2018.06.007","article-title":"RNA interfering molecule delivery from in situ forming biodegradable hydrogels for enhancement of bone formation in rat calvarial bone defects.","volume":"75","author":"Nguyen","year":"2018","journal-title":"Acta Biomater."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30435-7","article-title":"Implication of SARS-CoV-2 evolution in the sensitivity of RT-qPCR diagnostic assays.","author":"Os\u00f3rio","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"26210","DOI":"10.1074\/jbc.M111.229856","article-title":"Retinoic acid-inducible gene I-inducible miR-23b inhibits infections by minor group rhinoviruses through down-regulation of the very low density lipoprotein receptor.","volume":"286","author":"Ouda","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/srep23007","article-title":"Circulating human cytomegalovirus-encoded HCMV-miR-US4-1 as an indicator for predicting the efficacy of IFN\u03b1 treatment in chronic hepatitis B patients.","volume":"6","author":"Pan","year":"2016","journal-title":"Sci. Rep."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/mBio.00198-11","article-title":"Integrative deep sequencing of the mouse lung transcriptome reveals differential expression of diverse classes of small RNAs in response to respiratory virus infection.","volume":"2","author":"Peng","year":"2011","journal-title":"mBio"},{"key":"B50","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nrmicro2147","article-title":"Coronaviruses post-SARS: update on replication and pathogenesis.","volume":"7","author":"Perlman","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1038\/mt.2016.166","article-title":"Viral vector-based targeting of miR-21 in cardiac nonmyocyte cells reduces pathologic remodeling of the heart.","volume":"24","author":"Ramanujam","year":"2016","journal-title":"Mol. Ther."},{"key":"B52","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nature05983","article-title":"Intronic microRNA precursors that bypass Drosha processing.","volume":"448","author":"Ruby","year":"2007","journal-title":"Nature"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcimb.2020.00317","article-title":"ACE2, much more than just a receptor for SARS-COV-2.","volume":"10","author":"Samavati","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.21.001586","article-title":"Comparative analyses of SAR-CoV2 genomes from different geographical locations and other coronavirus family genomes reveals unique features potentially consequential to host-virus interaction and pathogenesis.","author":"Sardar","year":"2020","journal-title":"bioRixv[Preprint]."},{"key":"B55","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev-virology-110615-042409","article-title":"Unraveling the mysterious interactions between hepatitis C virus RNA and liver-specific MicroRNA-122.","volume":"3","author":"Sarnow","year":"2016","journal-title":"Ann. Rev. Virol."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104793","article-title":"Remdesivir and SARS-CoV-2: structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites.","volume":"178","author":"Shannon","year":"2020","journal-title":"Anti. Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1261\/rna.032268.112","article-title":"Evidence for a cytoplasmic microprocessor of pri-miRNAs.","volume":"18","author":"Shapiro","year":"2012","journal-title":"RNA"},{"key":"B58","doi-asserted-by":"publisher","first-page":"4381","DOI":"10.1096\/fj.14-253534","article-title":"Novel microRNA-like viral small regulatory RNAs arising during human hepatitis A virus infection.","volume":"28","author":"Shi","year":"2014","journal-title":"FASEB J."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5885-9","article-title":"Epithelial-mesenchymal transition markers screened in a cell-based model and validated in lung adenocarcinoma.","volume":"19","author":"Song","year":"2019","journal-title":"BMC Cancer"},{"key":"B60","doi-asserted-by":"publisher","first-page":"8849","DOI":"10.1128\/jvi.00456-10","article-title":"Cellular MicroRNAs inhibit replication of the H1N1 Influenza A virus in infected cells.","volume":"84","author":"Song","year":"2010","journal-title":"J. Virol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/rmv.1894","article-title":"The role of microRNAs in respiratory viral infection: friend or foe?","volume":"26","author":"Tahamtan","year":"2016","journal-title":"Rev. Med. Virol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1093\/nsr\/nwaa036","article-title":"On the origin and continuing evolution of SARS-CoV-2.","volume":"7","author":"Tang","year":"2020","journal-title":"Natl. Sci. Rev."},{"key":"B63","doi-asserted-by":"publisher","first-page":"4659","DOI":"10.1007\/s12035-016-0007-z","article-title":"Lentiviral delivery of miR-133b improves functional recovery after spinal cord injury in mice.","volume":"54","author":"Theis","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-10-185","article-title":"Cytoplasmic RNA viruses as potential vehicles for the delivery of therapeutic small RNAs.","volume":"10","author":"Usme-Ciro","year":"2013","journal-title":"Virol. J."},{"key":"B65","doi-asserted-by":"publisher","first-page":"190","DOI":"10.4161\/rna.8.2.13983","article-title":"Implications of RNA virus-produced miRNAs.","volume":"8","author":"Varble","year":"2011","journal-title":"RNA Biol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.omtn.2019.07.002","article-title":"The function and therapeutic potential of epstein-barr virus-encoded MicroRNAs in cancer.","volume":"17","author":"Wang","year":"2019","journal-title":"Mol. Ther. Nucl. Acids"},{"key":"B67","year":"2020","journal-title":"Coronavirus Disease COVID-19 Pandemic."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.aax0902","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"B69","doi-asserted-by":"publisher","first-page":"9345","DOI":"10.1128\/jvi.75.19.9345-9356.2001","article-title":"Localization to the nucleolus is a common feature of coronavirus nucleoproteins, and the protein may disrupt host cell division.","volume":"75","author":"Wurm","year":"2001","journal-title":"J. Virol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms19113381","article-title":"Microrna-221-5p inhibits porcine epidemic diarrhea virus replication by targeting genomic viral rna and activating the nf-\u03bab pathway.","volume":"19","author":"Zheng","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.micpath.2018.05.015","article-title":"Comparative analysis of MicroRNA expression in dog lungs infected with the H3N2 and H5N1 canine influenza viruses.","volume":"121","author":"Zheng","year":"2018","journal-title":"Microb. Pathog."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.ymthe.2018.02.020","article-title":"Exosomes from endothelial progenitor cells improve the outcome of a murine model of sepsis.","volume":"26","author":"Zhou","year":"2018","journal-title":"Mol. Ther."},{"key":"B73","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.virol.2006.07.046","article-title":"Coronavirus nucleocapsid protein is an RNA chaperone.","volume":"357","author":"Z\u00fa\u00f1iga","year":"2007","journal-title":"Virology"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2020.571553\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T11:28:12Z","timestamp":1600428492000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2020.571553\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,18]]},"references-count":73,"alternative-id":["10.3389\/fmicb.2020.571553"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2020.571553","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,18]]},"article-number":"571553"}}